Studies tried to use NGAL to differentiate between various types of stable CKD, but failed [27], whereas pNGAL was proved to be able to predict the AKI occurrence and outcome in ADHF, but the reliability of its predictive value remains controversial [6,28], and more investigations are still needed before its wide application in clinical practice. This evidence concerns the gene LCN2 and chronic kidney disease.